- Supporting Ebola Response: Rapid Diagnostics and Global Expertise
- ADLM 2026
- Protecting Food. Protecting People.
- Annual Report: Achievements Building a Healthier Future
- AMR is Rising — Stewardship Demands Global Leadership
News
bioMérieux's Q2 2026 sales totaled €981 million, with solid organic growth at +5%, reaching +7% excluding BIOFIRE® respiratory panels. The sales of the GO•28 growth drivers increased by 8.5% organically in Q2 26.
Swipe for more stories
-
Tracking the Cyclospora cayetanensis Outbreak in the United States
bioMérieux's unique portfolio of clinical diagnostic and wastewater surveillance solutions can support community health and medical professionals in responding to the current outbreak.
-
bioMérieux to Showcase Company’s Latest in Diagnostic Innovations at ADLM 2026
bioMérieux announced it will showcase its latest diagnostic solutions and innovations at the 2026 Association for Diagnostics & Laboratory Medicine (ADLM) Annual Conference & Clinical Lab Expo. -
bioMérieux Launches PCR Testing Solution to Verify Probiotic Species in Dietary Supplements Manufacturing
With GENE-UP® PROBIOTIC SPECIES ID, bioMérieux introduces a first-of-its-kind commercialized species-level identification PCR solution for in-house quality control teams and external laboratory partners.
Enabling Decision-Making
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19